Investments in progress
We are out there looking for the next big thing or at the office analyzing, verifying the facts, and drafting agreements. Sign up and we will let you know once have found something great.
Our portfolio companies
Our portfolio companies are currently developing diagnostics for early detection of cancer via blood sample, saving lives in emergency care and surgery through software innovations, developing personalised treatments of severe diseases, and much more.
Synartro is developing a unique treatment for knee osteoarthritis by combining two well-tried drugs, which will offer an effective and safe alternative to today’s treatments.
Former portfolio companies that have reached new heights through acquisition or listing, and continue to thrive under new ownership. These companies continue to make a lasting impact in their respective industries.